No Data
No Data
JPMorgan Adjusts Price Target on Elevance Health to $655 From $631
Centene Posts Q2 Beat Despite Medicaid Headwinds
Express News | Elevance Health Inc : JP Morgan Raises Target Price to $655 From $631
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $10,000 Today
Community Health (CYH) Q2 Earnings Miss on Lower Patient Days
Universal Health (UHS) Q2 Earnings Beat on Acute Care Strength
No Data